FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562054892> ?p ?o ?g. }

• W2562054892 endingPage "422" @default.
• W2562054892 startingPage "422" @default.
• W2562054892 abstract "Deutetrabenazine, an inhibitor of vesicular monoamine transporter type 2 (VMAT2) depletes presynaptic dopamine and is useful in the treatment of hyperkinetic movement disorders. This study explored the safety, tolerability, and preliminary efficacy of deutetrabenazine in adolescents with moderate-to-severe tics associated with Tourette syndrome (TS).In this open-label study of 12-18-year-old patients with TS-related tics, deutetrabenazine was titrated up to 36 mg/day over 6 weeks to adequately suppress tics without bothersome adverse effects (AEs), followed by maintenance at optimal dose for 2 weeks. An independent blinded rater assessed tic severity using the Yale Global Tic Severity Scale (YGTSS), which was the primary outcome measure. Secondary outcome measures included the TS Clinical Global Impression (TS-CGI) and TS Patient Global Impression of Change (TS-PGIC).Twenty-three enrolled patients received deutetrabenazine and had at least 1 post-baseline YGTSS assessment. The mean (SD [standard deviation]) baseline YGTSS Total Tic Severity Score (TTS) was 31.6 (7.9) and had decreased by 11.6 (8.2) points at week 8, a 37.6% reduction in tic severity (p<0.0001). The TS-CGI score improved by 1.2 (0.81) points (p<0.0001) and the TS-PGIC results at week 8 indicated that 76% of patients were much improved or very much improved compared with baseline. The mean (SD) daily deutetrabenazine dose at week 8 was 32.1 (6.6) mg (range 18-36 mg). One week after withdrawal of deutetrabenazine, the TTS scores increased by 5.6 (8.4) points, providing confirmation of the drug effect. No serious or severe adverse events were reported.The results of this open-label 8-week study suggest that deutetrabenazine is safe and associated with improvement in tic severity in adolescents with TS and troublesome tics." @default.
• W2562054892 created "2017-01-06" @default.
• W2562054892 creator A5008039287 @default.
• W2562054892 creator A5031288381 @default.
• W2562054892 creator A5051528792 @default.
• W2562054892 creator A5054891890 @default.
• W2562054892 creator A5055252759 @default.
• W2562054892 creator A5068655451 @default.
• W2562054892 creator A5073573130 @default.
• W2562054892 date "2016-01-01" @default.
• W2562054892 modified "2023-10-17" @default.
• W2562054892 title "Deutetrabenazine in Tics Associated with Tourette Syndrome." @default.
• W2562054892 cites W1509695694 @default.
• W2562054892 cites W1591577368 @default.
• W2562054892 cites W1916406106 @default.
• W2562054892 cites W1932455908 @default.
• W2562054892 cites W1965439467 @default.
• W2562054892 cites W1981200642 @default.
• W2562054892 cites W1981277671 @default.
• W2562054892 cites W2016752139 @default.
• W2562054892 cites W2019101336 @default.
• W2562054892 cites W2030149708 @default.
• W2562054892 cites W2030332993 @default.
• W2562054892 cites W2036284238 @default.
• W2562054892 cites W2044390895 @default.
• W2562054892 cites W2101484226 @default.
• W2562054892 cites W2102395233 @default.
• W2562054892 cites W2117670094 @default.
• W2562054892 cites W2120974260 @default.
• W2562054892 cites W2125405653 @default.
• W2562054892 cites W2153846694 @default.
• W2562054892 cites W2164558077 @default.
• W2562054892 cites W2254007091 @default.
• W2562054892 cites W2287456410 @default.
• W2562054892 cites W2294027246 @default.
• W2562054892 cites W2337201199 @default.
• W2562054892 cites W2475146005 @default.
• W2562054892 cites W4249617937 @default.
• W2562054892 doi "https://doi.org/10.7916/d8m32w3h" @default.
• W2562054892 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5133390" @default.
• W2562054892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27917309" @default.
• W2562054892 hasPublicationYear "2016" @default.
• W2562054892 type Work @default.
• W2562054892 sameAs 2562054892 @default.
• W2562054892 citedByCount "19" @default.
• W2562054892 countsByYear W25620548922016 @default.
• W2562054892 countsByYear W25620548922017 @default.
• W2562054892 countsByYear W25620548922018 @default.
• W2562054892 countsByYear W25620548922019 @default.
• W2562054892 countsByYear W25620548922020 @default.
• W2562054892 countsByYear W25620548922021 @default.
• W2562054892 countsByYear W25620548922022 @default.
• W2562054892 countsByYear W25620548922023 @default.
• W2562054892 crossrefType "journal-article" @default.
• W2562054892 hasAuthorship W2562054892A5008039287 @default.
• W2562054892 hasAuthorship W2562054892A5031288381 @default.
• W2562054892 hasAuthorship W2562054892A5051528792 @default.
• W2562054892 hasAuthorship W2562054892A5054891890 @default.
• W2562054892 hasAuthorship W2562054892A5055252759 @default.
• W2562054892 hasAuthorship W2562054892A5068655451 @default.
• W2562054892 hasAuthorship W2562054892A5073573130 @default.
• W2562054892 hasConcept C118552586 @default.
• W2562054892 hasConcept C126322002 @default.
• W2562054892 hasConcept C142724271 @default.
• W2562054892 hasConcept C197934379 @default.
• W2562054892 hasConcept C204787440 @default.
• W2562054892 hasConcept C27081682 @default.
• W2562054892 hasConcept C2776000289 @default.
• W2562054892 hasConcept C2776284327 @default.
• W2562054892 hasConcept C2777026814 @default.
• W2562054892 hasConcept C2777200579 @default.
• W2562054892 hasConcept C2778375690 @default.
• W2562054892 hasConcept C513476851 @default.
• W2562054892 hasConcept C71924100 @default.
• W2562054892 hasConceptScore W2562054892C118552586 @default.
• W2562054892 hasConceptScore W2562054892C126322002 @default.
• W2562054892 hasConceptScore W2562054892C142724271 @default.
• W2562054892 hasConceptScore W2562054892C197934379 @default.
• W2562054892 hasConceptScore W2562054892C204787440 @default.
• W2562054892 hasConceptScore W2562054892C27081682 @default.
• W2562054892 hasConceptScore W2562054892C2776000289 @default.
• W2562054892 hasConceptScore W2562054892C2776284327 @default.
• W2562054892 hasConceptScore W2562054892C2777026814 @default.
• W2562054892 hasConceptScore W2562054892C2777200579 @default.
• W2562054892 hasConceptScore W2562054892C2778375690 @default.
• W2562054892 hasConceptScore W2562054892C513476851 @default.
• W2562054892 hasConceptScore W2562054892C71924100 @default.
• W2562054892 hasLocation W25620548921 @default.
• W2562054892 hasOpenAccess W2562054892 @default.
• W2562054892 hasPrimaryLocation W25620548921 @default.
• W2562054892 hasRelatedWork W2020414031 @default.
• W2562054892 hasRelatedWork W2086523228 @default.
• W2562054892 hasRelatedWork W2291398686 @default.
• W2562054892 hasRelatedWork W2339450775 @default.
• W2562054892 hasRelatedWork W2556981425 @default.
• W2562054892 hasRelatedWork W2562054892 @default.
• W2562054892 hasRelatedWork W2610508070 @default.
• W2562054892 hasRelatedWork W2743572617 @default.

• next